The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 02, 2022

Filed:

Oct. 15, 2018
Applicant:

Medtronic Vascular, Inc., Santa Rosa, CA (US);

Inventors:

Bradley Steele, Plymouth, MN (US);

Simone D'Onofrio, Brescia, IT;

Massimo Morero, Turin, IT;

Federica Bellucci, Alessandria, IT;

Cassandra Morris, Plymouth, MN (US);

Assignee:

Medtronic Vascular, Inc., Santa Rosa, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 9/16 (2006.01); A61F 2/82 (2013.01); A61M 25/00 (2006.01); A61L 29/16 (2006.01); A61P 5/44 (2006.01); A61K 31/56 (2006.01); A61K 31/337 (2006.01); A61L 31/10 (2006.01); A61P 29/00 (2006.01); A61L 31/16 (2006.01); A61K 31/436 (2006.01); A61L 29/08 (2006.01); A61M 25/10 (2013.01);
U.S. Cl.
CPC ...
A61L 29/16 (2013.01); A61F 2/82 (2013.01); A61K 9/0009 (2013.01); A61K 9/167 (2013.01); A61K 9/1676 (2013.01); A61K 31/337 (2013.01); A61K 31/436 (2013.01); A61K 31/56 (2013.01); A61L 29/085 (2013.01); A61L 31/10 (2013.01); A61L 31/16 (2013.01); A61M 25/0045 (2013.01); A61M 25/104 (2013.01); A61P 5/44 (2018.01); A61P 29/00 (2018.01); A61F 2210/009 (2013.01); A61F 2210/0076 (2013.01); A61F 2250/0067 (2013.01); A61L 2300/41 (2013.01); A61L 2300/416 (2013.01); A61L 2300/606 (2013.01); A61L 2300/624 (2013.01); A61L 2400/12 (2013.01); A61L 2420/04 (2013.01); A61L 2420/08 (2013.01); A61M 2025/0057 (2013.01); A61M 2025/0058 (2013.01); A61M 2025/105 (2013.01); A61M 2025/1075 (2013.01); A61M 2025/1088 (2013.01); A61M 2205/0238 (2013.01); A61M 2205/0288 (2013.01);
Abstract

A variety of nanoparticles or microparticles may be used to treat diseases such as restenosis or blood clots. For example, a nanoparticle or microparticle may include a core having a biodegradable polymer, an exterior having hydrophilic moieties. and a therapeutic agent. The nanoparticles may include targeting moieties that target the nanoparticle or microparticle to an arterial lesion. The nanoparticle or microparticle may include an exterior shell around the core to increase stability of the nanoparticle or microparticle. The nanoparticle or microparticle may include a magnetic particle to allow targeted delivery of the nanoparticle or microparticle via a magnetic field. The nanoparticles or microparticles may be coated on a medical device, such as a catheter balloon or a stent, or may be delivered systemically or locally to patients in need thereof.


Find Patent Forward Citations

Loading…